Mechanisms of alloantibody production in sensitized renal allograft recipients

Mark D Stegall, P. G. Dean, J. Gloor

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

While clinical protocols have been developed to allow for successful kidney transplantation in patients with high levels of donor-specific alloantibody (DSA), significant limitations still exist including high rates of early humoral rejection and decreased long-term graft survival compared to conventional transplants. A better understanding of the mechanisms of alloantibody production at baseline and at various phases posttransplant would be an important step toward the development of improved therapeutic approaches. The goal of this review is to outline recent studies regarding antibody production in general and specific studies that illustrate what is known about alloantibody production in sensitized patients.

Original languageEnglish (US)
Pages (from-to)998-1005
Number of pages8
JournalAmerican Journal of Transplantation
Volume9
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Isoantibodies
Allografts
Kidney
Graft Survival
Clinical Protocols
Kidney Transplantation
Antibody Formation
Tissue Donors
Transplants
Therapeutics

Keywords

  • Alloantibodies
  • B lymphocyte
  • Humoral rejection
  • Kidney transplantation
  • Plasma cells

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Mechanisms of alloantibody production in sensitized renal allograft recipients. / Stegall, Mark D; Dean, P. G.; Gloor, J.

In: American Journal of Transplantation, Vol. 9, No. 5, 05.2009, p. 998-1005.

Research output: Contribution to journalArticle

@article{bef36a51b1e148dab04d0fbbaf1790d8,
title = "Mechanisms of alloantibody production in sensitized renal allograft recipients",
abstract = "While clinical protocols have been developed to allow for successful kidney transplantation in patients with high levels of donor-specific alloantibody (DSA), significant limitations still exist including high rates of early humoral rejection and decreased long-term graft survival compared to conventional transplants. A better understanding of the mechanisms of alloantibody production at baseline and at various phases posttransplant would be an important step toward the development of improved therapeutic approaches. The goal of this review is to outline recent studies regarding antibody production in general and specific studies that illustrate what is known about alloantibody production in sensitized patients.",
keywords = "Alloantibodies, B lymphocyte, Humoral rejection, Kidney transplantation, Plasma cells",
author = "Stegall, {Mark D} and Dean, {P. G.} and J. Gloor",
year = "2009",
month = "5",
doi = "10.1111/j.1600-6143.2009.02612.x",
language = "English (US)",
volume = "9",
pages = "998--1005",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Mechanisms of alloantibody production in sensitized renal allograft recipients

AU - Stegall, Mark D

AU - Dean, P. G.

AU - Gloor, J.

PY - 2009/5

Y1 - 2009/5

N2 - While clinical protocols have been developed to allow for successful kidney transplantation in patients with high levels of donor-specific alloantibody (DSA), significant limitations still exist including high rates of early humoral rejection and decreased long-term graft survival compared to conventional transplants. A better understanding of the mechanisms of alloantibody production at baseline and at various phases posttransplant would be an important step toward the development of improved therapeutic approaches. The goal of this review is to outline recent studies regarding antibody production in general and specific studies that illustrate what is known about alloantibody production in sensitized patients.

AB - While clinical protocols have been developed to allow for successful kidney transplantation in patients with high levels of donor-specific alloantibody (DSA), significant limitations still exist including high rates of early humoral rejection and decreased long-term graft survival compared to conventional transplants. A better understanding of the mechanisms of alloantibody production at baseline and at various phases posttransplant would be an important step toward the development of improved therapeutic approaches. The goal of this review is to outline recent studies regarding antibody production in general and specific studies that illustrate what is known about alloantibody production in sensitized patients.

KW - Alloantibodies

KW - B lymphocyte

KW - Humoral rejection

KW - Kidney transplantation

KW - Plasma cells

UR - http://www.scopus.com/inward/record.url?scp=65249180708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249180708&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2009.02612.x

DO - 10.1111/j.1600-6143.2009.02612.x

M3 - Article

C2 - 19422329

AN - SCOPUS:65249180708

VL - 9

SP - 998

EP - 1005

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 5

ER -